Skip to main content
SpringerLink
Log in

Ocular Involvement in Autoimmune Blistering Skin Diseases

  • Chapter
  • First Online:
Blistering Diseases

  • 1333 Accesses

Abstract

Autoimmune blistering skin disease (AIBD) is a term used to describe a heterogeneous group of cutaneous and mucosal diseases with significant morbidity and mortality. A range of ocular complications can occur in patients with AIBD, due to the underlying blistering disease or as side effects of the medications used to treat these diseases. The most common ocular presentation of AIBD is a chronic conjunctivitis, which can progress to conjunctival fibrosis and eventually chronic cicatricial conjunctivitis. Cicatrisation leads to ocular complications that include symblepharon, fornix foreshortening, entropion, trichiasis, corneal damage and neovascularisation. Clinical features in the eye overlap between the types of AIBD. Early recognition and treatment of the disease is essential to prevent irreversible scarring and progression to blindness in certain cases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ekong AS, Foster CS, Roque MR. Eye involvement in autoimmune blistering diseases. Clin Dermatol. 2001;19(6):742–9.

    Article  CAS  PubMed  Google Scholar 

  2. Ahmed M, Zein G, Khawaja F, Foster CS. Ocular cicatricial pemphigoid: pathogenesis, diagnosis and treatment. Prog Retin Eye Res. 2004;23(6):579–92 [Review].

    Article  PubMed  Google Scholar 

  3. Hardy KM, Perry HO, Pingree GC, Kirby Jr TJ. Benign mucous membrane pemphigoid. Arch Dermatol. 1971;104(5):467–75.

    Article  CAS  PubMed  Google Scholar 

  4. Hanson RD, Olsen KD, Rogers 3rd RS. Upper aerodigestive tract manifestations of cicatricial pemphigoid. Ann Otol Rhinol Laryngol. 1988;97(5 Pt 1):493–9 [Case Reports].

    Article  CAS  PubMed  Google Scholar 

  5. Chan LS, Ahmed AR, Anhalt GJ, Bernauer W, Cooper KD, Elder MJ, et al. The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol. 2002;138(3):370–9 [Consensus Development Conference Research Support, Non-U.S. Gov’t Review].

    Article  PubMed  Google Scholar 

  6. Foster CS. Cicatricial pemphigoid. Trans Am Ophthalmol Soc. 1986;84:527–663 [Clinical Trial Historical Article].

    PubMed Central  CAS  PubMed  Google Scholar 

  7. Foster CS, Wilson LA, Ekins MB. Immunosuppressive therapy for progressive ocular cicatricial pemphigoid. Ophthalmology. 1982;89(4):340–53 [Case Reports Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.].

    Article  CAS  PubMed  Google Scholar 

  8. Chan LS. Mucous membrane pemphigoid. Clin Dermatol. 2001;19(6):703–11 [Review].

    Article  CAS  PubMed  Google Scholar 

  9. Thorne JE, Anhalt GJ, Jabs DA. Mucous membrane pemphigoid and pseudopemphigoid. Ophthalmology. 2004;111(1):45–52.

    Article  PubMed  Google Scholar 

  10. Higgins GT, Allan RB, Hall R, Field EA, Kaye SB. Development of ocular disease in patients with mucous membrane pemphigoid involving the oral mucosa. Br J Ophthalmol. 2006;90(8):964–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. Roufas A, Kim P, Reeves D, Sutton G. A rare unilateral case of ocular mucous membrane pemphigoid. Cornea. 2010;29(12):1462–4 [Case Reports].

    Article  PubMed  Google Scholar 

  12. Mutasim DF, Pelc NJ, Anhalt GJ. Cicatricial pemphigoid. Dermatol Clin. 1993;11(3):499–510.

    CAS  PubMed  Google Scholar 

  13. Schwab IR. Cultured corneal epithelia for ocular surface disease. Trans Am Ophthalmol Soc. 1999;97:891–986 [Case Reports Comparative Study Research Support, Non-U.S. Gov’t].

    PubMed Central  CAS  PubMed  Google Scholar 

  14. Liesegang TJ. Conjunctival changes associated with glaucoma therapy: implications for the external disease consultant and the treatment of glaucoma. Cornea. 1998;17(6):574–83 [Comparative Study Review].

    Article  CAS  PubMed  Google Scholar 

  15. Eschle-Meniconi ME, Ahmad SR, Foster CS. Mucous membrane pemphigoid: an update. Curr Opin Ophthalmol. 2005;16(5):303–7 [Research Support, Non-U.S. Gov’t Review].

    Article  PubMed  Google Scholar 

  16. Foster CS, Ahmed AR. Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid: a preliminary study. Ophthalmology. 1999;106(11):2136–43 [Clinical Trial].

    Article  CAS  PubMed  Google Scholar 

  17. Heiligenhaus A, Shore JW, Rubin PA, Foster CS. Long-term results of mucous membrane grafting in ocular cicatricial pemphigoid. Implications for patient selection and surgical considerations. Ophthalmology. 1993;100(9):1283–8.

    Article  CAS  PubMed  Google Scholar 

  18. Rauz S, Maddison PG, Dart JKG. Evaluation of mucous membrane pemphigoid with ocular involvement in young patients. Ophthalmology. 2005;112(7):1268–74 [Comparative Study].

    Article  PubMed  Google Scholar 

  19. Mondino BJ, Brown SI. Ocular cicatricial pemphigoid. Ophthalmology. 1981;88(2):95–100 [Research Support, U.S. Gov’t, P.H.S.].

    Article  CAS  PubMed  Google Scholar 

  20. Tauber J, Jabbur N, Foster CS. Improved detection of disease progression in ocular cicatricial pemphigoid. Cornea. 1992;11(5):446–51.

    Article  CAS  PubMed  Google Scholar 

  21. Hopkinson SB, Baker SE, Jones JC. Molecular genetic studies of a human epidermal autoantigen (the 180-kD bullous pemphigoid antigen/BP180): identification of functionally important sequences within the BP180 molecule and evidence for an interaction between BP180 and alpha 6 integrin. J Cell Biol. 1995;130(1):117–25 [Research Support, U.S. Gov’t, P.H.S.].

    Article  CAS  PubMed  Google Scholar 

  22. Weinberg MA, Insler MS, Campen RB. Mucocutaneous features of autoimmune blistering diseases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;84(5):517–34 [Review].

    Article  CAS  PubMed  Google Scholar 

  23. Aultbrinker EA, Starr MB, Donnenfeld ED. Linear Iga disease—the ocular manifestations. Ophthalmology. 1988;95(3):340–3.

    Article  CAS  PubMed  Google Scholar 

  24. Elchahal S, Kavosh ER, Chu DS. Ocular manifestations of blistering diseases. Immunol Allergy Clin North Am. 2008;28(1):119–36 [Review].

    Article  PubMed  Google Scholar 

  25. Talhari C, Althaus C, Megahed M. Ocular linear IgA disease resulting in blindness. Arch Dermatol. 2006;142(6):786–7 [Case Reports Letter].

    Article  PubMed  Google Scholar 

  26. Sitaru C, Mihai S, Otto C, Chiriac MT, Hausser I, Dotterweich B, et al. Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen. J Clin Invest. 2005;115(4):870–8 [Research Support, Non-U.S. Gov’t].

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  27. Sitaru C, Chiriac MT, Mihai S, Buning J, Gebert A, Ishiko A, et al. Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice. J Immunol. 2006;177(5):3461–8 [Research Support, Non-U.S. Gov’t].

    Article  CAS  PubMed  Google Scholar 

  28. Mihai S, Chiriac MT, Takahashi K, Thurman JM, Holers VM, Zillikens D, et al. The alternative pathway of complement activation is critical for blister induction in experimental epidermolysis bullosa acquisita. J Immunol. 2007;178(10):6514–21 [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t].

    Article  CAS  PubMed  Google Scholar 

  29. Woodley DT, Ram R, Doostan A, Bandyopadhyay P, Huang Y, Remington J, et al. Induction of epidermolysis bullosa acquisita in mice by passive transfer of autoantibodies from patients. J Invest Dermatol. 2006;126(6):1323–30 [Research Support, N.I.H., Extramural].

    Article  CAS  PubMed  Google Scholar 

  30. Gammon WR. Epidermolysis bullosa acquisita: a disease of autoimmunity to type VII collagen. J Autoimmun. 1991;4(1):59–71 [Research Support, U.S. Gov’t, P.H.S. Review].

    Article  CAS  PubMed  Google Scholar 

  31. Zambruno G, Manca V, Kanitakis J, Cozzani E, Nicolas JF, Giannetti A. Linear IgA bullous dermatosis with autoantibodies to a 290 kd antigen of anchoring fibrils. J Am Acad Dermatol. 1994;31(5 Pt 2):884–8 [Case Reports].

    Article  CAS  PubMed  Google Scholar 

  32. Hashimoto T, Ishiko A, Shimizu H, Tanaka T, Dodd HJ, Bhogal BS, et al. A case of linear IgA bullous dermatosis with IgA anti-type VII collagen autoantibodies. Br J Dermatol. 1996;134(2):336–9 [Case Reports Research Support, Non-U.S. Gov’t].

    Article  CAS  PubMed  Google Scholar 

  33. Caux F, Kirtschig G, Lemarchand-Venencie F, Venencie PY, Hoang-Xuan T, Robin H, et al. IgA-epidermolysis bullosa acquisita in a child resulting in blindness. Br J Dermatol. 1997;137(2):270–5 [Case Reports Research Support, Non-U.S. Gov’t].

    Article  CAS  PubMed  Google Scholar 

  34. Bauer JW, Schaeppi H, Metze D, Muss W, Pohla-Gubo G, Hametner R, et al. Ocular involvement in IgA-epidermolysis bullosa acquisita. Br J Dermatol. 1999;141(5):887–92 [Case Reports Research Support, Non-U.S. Gov’t].

    Article  CAS  PubMed  Google Scholar 

  35. Kasperkiewicz M, Zillikens D. Rituximab (anti-CD20) for the treatment of autoimmune bullous diseases. Hautarzt. 2007;58(2):115–6 [English Abstract Review].

    Article  CAS  PubMed  Google Scholar 

  36. Letko E, Bhol K, Anzaar F, Perez VL, Ahmed AR, Foster CS. Chronic cicatrizing conjunctivitis in a patient with epidermolysis bullosa acquisita. Arch Ophthalmol. 2006;124(11):1615–8 [Case Reports].

    Article  PubMed  Google Scholar 

  37. Hodak E, Kremer I, David M, Hazaz B, Rothem A, Feuerman P, et al. Conjunctival involvement in pemphigus vulgaris: a clinical, histopathological and immunofluorescence study. Br J Dermatol. 1990;123(5):615–20.

    Article  CAS  PubMed  Google Scholar 

  38. Smith RJ, Manche EE, Mondino BJ. Ocular cicatricial pemphigoid and ocular manifestations of pemphigus vulgaris. Int Ophthalmol Clin. 1997;37(2):63–75.

    Article  CAS  PubMed  Google Scholar 

  39. Merchant S, Weinstein M. Pemphigus vulgaris: the eyes have it. Pediatrics. 2003;112(1):183–5.

    Article  PubMed  Google Scholar 

  40. Schwab IR, Plotnik RD, Mannis MJ. Pemphigus and pemphigoid. Arch Ophthalmol. 1992;110(2):171 [Letter].

    Article  CAS  PubMed  Google Scholar 

  41. Fiore JM, Perry HD, Donnenfeld ED, Berger SA. Pemphigus vulgaris: bilateral plica semilunaris involvement. Cornea. 2011;30(3):357–9 [Case Reports].

    Article  PubMed  Google Scholar 

  42. Daoud YJ, Cervantes R, Foster CS, Ahmed AR. Ocular pemphigus. J Am Acad Dermatol. 2005;53(4):585–90.

    Article  PubMed  Google Scholar 

  43. Bean SF, Halubar K, Gillett RB. Pemphigus involving the eyes. Arch Dermatol. 1975;111(11):1484–6 [Case Reports].

    Article  CAS  PubMed  Google Scholar 

  44. Frith PA, Venning VA, Wojnarowska F, Millard PR, Bron AJ. Conjunctival involvement in cicatricial and bullous pemphigoid: a clinical and immunopathological study. Br J Ophthalmol. 1989;73(1):52–6.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  45. Kiyokawa C, Fujito S, Mori O, Mochizuki M, Hashimoto T. Bullous pemphigoid showing unusual ocular changes. Br J Dermatol. 1998;139(4):693–6 [Case Reports].

    Article  CAS  PubMed  Google Scholar 

  46. Beele H, Claerhout I, Kestelyn P, Dierckxens L, Naeyaert JM, De Laey JJ. Bilateral corneal melting in a patient with paraneoplastic pemphigus. Dermatology. 2001;202(2):147–50 [Case Reports].

    Article  CAS  PubMed  Google Scholar 

  47. Hayanga AJ, Lee TM, Pannucci CJ, Knipp BS, Olsen SH, Wang SC, et al. Paraneoplastic pemphigus in a burn intensive care unit: case report and review of the literature. J Burn Care Res. 2010;31(5):826–9 [Case Reports Research Support, N.I.H., Extramural Review].

    Article  PubMed  Google Scholar 

  48. Hochman MA, Mayers M. Stevens-Johnson syndrome, epidermolysis bullosa, staphylococcal scalded skin syndrome, and dermatitis herpetiformis. Int Ophthalmol Clin. 1997;37(2):77–92.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, St. George Hospital, University of NSW Medical School, Sydney, NSW, Australia

    Jeremy C. K. Tan BSci (Med), MD & Dédée F. Murrell MA(Camb),BMBCh(Oxf),FAAD,MD,FACD,FRCP

  2. Department of Ophthalmology, Prince of Wales Hospital Sydney, Sydney, NSW, Australia

    Minas Coroneo MSc, MD, MS, FRACS, FRANZCO

Authors
  1. Jeremy C. K. Tan BSci (Med), MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dédée F. Murrell MA(Camb),BMBCh(Oxf),FAAD,MD,FACD,FRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Minas Coroneo MSc, MD, MS, FRACS, FRANZCO
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Minas Coroneo MSc, MD, MS, FRACS, FRANZCO .

Editor information

Editors and Affiliations

  1. Department of Dermatology, St George Hospital, University of New South Wales, Sydney, New South Wales, Australia

    Dédée F. Murrell

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Tan, J.C.K., Murrell, D.F., Coroneo, M. (2015). Ocular Involvement in Autoimmune Blistering Skin Diseases. In: Murrell, D. (eds) Blistering Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45698-9_45

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-45698-9_45

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-45697-2

  • Online ISBN: 978-3-662-45698-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation